Breath Analysis by Ion Mobility Spectrometry
Rekrutierend
NCT-Nummer:
NCT00632307
Studienbeginn:
Juli 2006
Letztes Update:
24.08.2022
Wirkstoff:
-
Indikation (Clinical Trials):
Lung Diseases
Geschlecht:
Alle
Altersgruppe:
Erwachsene (18+)
Phase:
-
Sponsor:
Lung Clinic Hemer
Collaborator:
-
Studienleiter
Michael Westhoff, MD
Principal Investigator
Lung Clinic Hemer, 58675 Hemer, Germany
Kontakt
Michael Westhoff, MD
Kontakt:
Phone: 004923729082203
E-Mail: michael.westhoff@lkhemer.de» Kontaktdaten anzeigen
Patric Litterst, MD
Kontakt:
Phone: 004923729082545
E-Mail: pneumologie@lkhemer.de» Kontaktdaten anzeigen
Detailed Description:
Recruitment of patients with different lung diseases goes on. First sub-group analysis of
patients with COPD,lung cancer and sarcoidosis is done in order to create a training set of
VOC-clusters for further validation in a bigger population of patients.
Inclusion Criteria:
- Any patient
- Ages 18-90 years old
Exclusion criteria:
- Patient who are not able to perform an exhalation manoever.
Primary outcome:
1. Identification of diseases specific VOCs (Time Frame - years)
Secondary outcome:
1. Change of disease specific VOCs under therapy (Time Frame - years)
- 1
COPD - 2
lung cancer - 3
airway infection - 4
interstitial lung disease - 5
sleep apnea - 6
pulmonary disorders with pleural infusions - 7
sarcoidosis - 8
healthy persons
Quelle: ClinicalTrials.gov
Sie können folgenden Inhalt einem Kollegen empfehlen:
"Breath Analysis by Ion Mobility Spectrometry"
Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.
Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!
